UK markets closed

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1850-0.0350 (-1.09%)
As of 03:13PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.2200
Open3.2000
Bid3.1700 x 1000
Ask3.2100 x 1300
Day's range3.1850 - 3.2300
52-week range3.0700 - 8.8000
Volume3,695
Avg. volume12,387
Market cap35.109M
Beta (5Y monthly)-0.34
PE ratio (TTM)N/A
EPS (TTM)-2.2040
Earnings date01 Mar 2023 - 06 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.00
  • Business Wire

    LENSAR to Present at Two Upcoming Investor Conferences

    ORLANDO, Fla., November 22, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences:

  • Business Wire

    LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

    ORLANDO, Fla., November 09, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2022 and provided a business update.

  • Business Wire

    LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

    ORLANDO, Fla., November 02, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s third quarter 2022 financial results will be released before market open on Wednesday, November 9, 2022. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, November 9, 2022 to discuss the financial results and re